The Microcirculation, Dialysis Modality and Sequestered Salt
NCT: NCT06327750 · RECRUITING
Brief Summary
The aim of this clinical trial is to investigate the effect of 5 different dialysis treatments (combinations of dialysis mode and dialysis fluid sodium content) on the microcirculation (MC) and sequestered sodium content (SSC) in adult prevalent end-stage kidney disease (ESKD) patients treated with hemodialysis (HD) or hemodiafiltration (HDF). The main questions it aims to answer are: 1. What are the effects on the sequestered sodium content and microcirculation after 4 weeks of treatment with the following dialysis modes? * HDF with an expected zero diffusive sodium balance (Dialysate sodium concentration (DNa)= Plasma sodium concentration (PNa)) compared to * HDF with an expected diffusive sodium efflux (DNa \< PNa, difference 3 mmol/L) compared to * HD with an expected zero diffusive sodium balance (DNa = PNa) compared to * HD with an expected diffusive sodium efflux (DNa \< PNa, difference 3 mmol/L) compared to * Isolated ultrafiltration for 30 minutes followed by HD with an expected zero diffusive sodium balance (DNa = PNa) 2. Are the SSC and MC interrelated in this patient group? This study is a randomized cross-over trial. Participants will be subjected to the abovementioned dialysis treatment modes in random order.
Frequently Asked Questions
What is The Microcirculation, Dialysis Modality and Sequestered Salt?
The Microcirculation, Dialysis Modality and Sequestered Salt is a clinical trial registered under NCT06327750. Current status: RECRUITING.
What is the status of NCT06327750?
The current status of NCT06327750 (The Microcirculation, Dialysis Modality and Sequestered Salt) is: RECRUITING.
When did The Microcirculation, Dialysis Modality and Sequestered Salt start?
The Microcirculation, Dialysis Modality and Sequestered Salt started on 2026-06-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.